DiaMedica Therapeutics, Inc. (DMAC)

7.25 +0.01 (+0.14%) USD  |  NASDAQ  |  Mar 13, 10:31
More

DiaMedica Therapeutics EPS Diluted (Quarterly) : -0.1737 for Sept. 30, 2025

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for DMAC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
XOMA Royalty Corp. 0.6991
Bristol Myers Squibb Co. 0.5326
Avantor, Inc. 0.0771
ACADIA Pharmaceuticals, Inc. 1.596
Alnylam Pharmaceuticals, Inc. 1.368

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -8.62M
Total Expenses (Quarterly) 8.62M
Enterprise Value 321.99M
Earnings Yield -9.89%
Normalized Earnings Yield -9.894